Data protection Impressum

Digital Health

Biopôle is joining forces with Swiss Healthcare Startups to extend the Vanguard accelerator to digital health start-ups in German-speaking Switzerland, while also welcoming Hôpital de La Tour to its Corporate Partnership Programme.

Biopôle expands its accelerator program and welcomes new corporate partner

5 August 2024

Revinax, founded in 2015 by neurosurgeon Maxime Ros in Montpellier, has decided to expand its activities by setting up at the Biopôle in Lausanne.

French company Revinax establishes operations at the Biopôle in Lausanne

3 July 2024

BioAlps, the life sciences cluster of Western Switzerland, offers a dynamic network, an innovative and supportive environment and direct access to the region's vibrant life sciences ecosystem.

BioAlps, Western Switzerland’s life sciences cluster

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2024)

26 June 2024

Doctolib, a leading European healthtech company based in Berlin, has announced the acquisition of Typeless, an EPFL spin-off specializing in AI speech recognition technology.

Doctolib acquires Typeless to enhance AI capabilities in healthcare

24 June 2024

Aktiia has received CE mark approval for its non-cuff optical technology, enabling the start-up to access markets in over 40 countries.

Aktiia’s CE Mark approval opens doors to international expansion

17 June 2024

Dandelion Science and the Wyss Center Geneva have announced a partnership to develop a generative AI platform for non-invasive brain therapies.

Dandelion Science partners with Wyss Center to pioneer AI-based brain therapies

12 June 2024

The Tech4Trust program awarded Brightside AI as the top start-up in its season 5 finale, celebrating its exceptional contributions to digital trust and security.

Brightside AI wins top prize at the Tech4Trust 2024 awards

11 June 2024

ORamaVR is set to enhance its innovative VR solutions for medical training with new support from Innosuisse's Scale-up Coaching program.

ORamaVR receives Scale-up Award from Innosuisse to accelerate growth

15 May 2024

Ikerian AG, along with its subsidiary RetinAI, has successfully completed a USD 6.18 million Series A extension financing round to propel the development and commercial rollout of innovative medical technologies.

Ikerian, parent company of RetinAI, secures USD 6.18 million for AI-driven medical advancements

13 May 2024

1 2 3 4 5 6 7 8 9 … 12